Semaphorin 4C accelerates disease progression and enables disease detection in breast cancer
Huayi Li(Tongji Hospital), Qinglei Gao(Tongji Hospital), Yu Xia(Chongqing Technology and Business University), Xin Li(Hubei University of Medicine), Sen Xu(Zhejiang Chinese Medical University), Hongfeng Zhang(Tianjin University of Science and Technology)
Cited by 3
Related Papers
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
|Clinical Microbiology and Infection|2016|376
New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk
|Nature Communications|2016|318
TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
|Oncotarget|2017|146
Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells
|Autophagy|2015|143
Metformin targets c-MYC oncogene to prevent prostate cancer
|Carcinogenesis|2013|141